State of Mississippi - University of Mississippi Medical Center

State of Mississippi - University of Mississippi Medical Center was paid $506.72M by Medicaid between Jan 2018 and Dec 2024, across 1278 billing codes. Its largest line is 99284, emergency room visit (serious) — 7.1% of everything it billed.

Compared with peers

Next to other General Acute Care Hospital providers in Mississippi

Rank by total paid#1 of 77

Median peer was paid$8.23M

This provider vs. median62×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,572,285	$79.07M
2019	1,522,368	$81.63M
2020	1,257,730	$64.21M
2021	1,462,986	$74.91M
2022	1,601,732	$71.56M
2023	1,523,060	$76.33M
2024incomplete	1,095,975	$59.00M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	7.1%	206,015	169,148	$36.16M
G0378	Hospital observation service, per hour	5.4%	42,333	31,676	$27.38M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	4.8%	240,282	204,376	$24.50M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.8%	105,125	85,877	$24.31M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	3.8%	355,806	311,459	$19.47M
42820	Tonsillectomy and adenoidectomy; younger than age 12	2.8%	6,393	5,168	$14.18M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	2.5%	322,995	277,959	$12.91M
J9271	Injection, pembrolizumab, 1 mg	2.4%	1,990	1,300	$12.26M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	1.7%	10,976	9,038	$8.55M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.5%	53,114	46,652	$7.62M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	1.3%	35,653	31,098	$6.43M
86902		1.2%	21,040	7,108	$6.07M

1266 more codes

J0585	Injection, onabotulinumtoxina, 1 unit	1.2%	7,600	$5.90M
99215	Doctor's office visit, returning patient (complex)	1.1%	73,018	$5.37M
99469	Subsequent inpatient neonatal critical care, per day, 28 days or younger	1.0%	20,497	$5.26M
99233	Hospital visit by a doctor, follow-up day (complex)	1.0%	115,857	$5.16M
99472	Subsequent inpatient pediatric critical care, per day, 2-5 years	<1%	20,840	$4.91M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	28,970	$4.58M
99232	Hospital visit by a doctor, follow-up day	<1%	131,523	$4.56M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	26,489	$4.44M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	40,792	$4.32M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	53,463	$3.54M
86885		<1%	47,024	$3.42M
A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	<1%	1,969	$3.27M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	32,204	$3.11M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	19,235	$3.08M
94375		<1%	22,412	$3.03M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	1,655	$2.92M
J2323	Injection, natalizumab, 1 mg	<1%	1,727	$2.87M
77386		<1%	12,195	$2.84M
99244	Office or other outpatient consultation, moderate to high complexity	<1%	26,750	$2.84M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	84,517	$2.79M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	6,189	$2.77M
J2505	Injection, pegfilgrastim, 6 mg	<1%	1,101	$2.77M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	118,075	$2.71M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	22,817	$2.64M
71045	Radiologic examination, chest; single view	<1%	239,658	$2.62M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	320,888	$2.55M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	32,844	$2.53M
86900		<1%	47,838	$2.52M
36430		<1%	13,172	$2.51M
76820		<1%	67,811	$2.51M
99479	Subsequent intensive care, per day, very low birth weight infant	<1%	26,744	$2.47M
54161		<1%	2,541	$2.46M
78815	Positron emission tomography (PET) for limited area imaging	<1%	6,592	$2.42M
42830		<1%	1,515	$2.39M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	30,836	$2.33M
J9312	Injection, rituximab, 10 mg	<1%	916	$2.31M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	75,636	$2.28M
20680		<1%	1,668	$2.28M
76819	Fetal biophysical profile; without non-stress testing	<1%	47,975	$2.22M
J2357	Injection, omalizumab, 5 mg	<1%	2,292	$2.21M
99243		<1%	28,575	$2.13M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	23,485	$2.09M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	19,008	$2.08M
71046	Radiologic examination, chest; 2 views	<1%	77,369	$2.04M
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	60,216	$2.02M
64642		<1%	9,411	$1.98M
80053	Comprehensive metabolic panel	<1%	222,646	$1.97M
95812		<1%	15,180	$1.93M
99204	Doctor's office visit, new patient (more involved)	<1%	25,447	$1.90M
76770		<1%	34,387	$1.90M
P9016	Red blood cells, leukocytes reduced, each unit	<1%	11,425	$1.87M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	4,931	$1.80M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	14,973	$1.78M
J0897	Injection, denosumab, 1 mg	<1%	2,674	$1.73M
70450	Computed tomography, head or brain; without contrast material	<1%	47,485	$1.71M
87428		<1%	23,300	$1.69M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	43,107	$1.66M
93304		<1%	11,346	$1.64M
J9299	Injection, nivolumab, 1 mg	<1%	279	$1.58M
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	60,503	$1.54M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	22,925	$1.50M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	256,322	$1.44M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	14,045	$1.41M
A0436	Rotary wing air mileage, per statute mile	<1%	1,964	$1.38M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	53,872	$1.37M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	38,347	$1.35M
88307		<1%	15,018	$1.34M
81229		<1%	2,919	$1.33M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	53,907	$1.27M
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	82,205	$1.25M
92587		<1%	7,797	$1.19M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	23,757	$1.15M
90791	Psychiatric diagnostic evaluation	<1%	13,764	$1.15M
96361	Intravenous infusion, hydration; each additional hour	<1%	26,423	$1.14M
J9035	Injection, bevacizumab, 10 mg	<1%	723	$1.12M
74018		<1%	70,404	$1.12M
49580		<1%	567	$1.12M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	16,899	$1.11M
36415	Collection of venous blood by venipuncture	<1%	367,472	$1.11M
95716		<1%	2,369	$1.10M
86923		<1%	15,615	$1.10M
95951		<1%	3,235	$1.07M
86922		<1%	12,464	$1.05M
90837	Psychotherapy session, about an hour	<1%	13,975	$1.04M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,598	$1.02M
99238	Hospital discharge day management, 30 minutes or less	<1%	21,830	$1.02M
J0475	Injection, baclofen, 10 mg	<1%	1,701	$1.02M
J1951	Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg	<1%	64	$1.02M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	25,835	$1.01M
72082		<1%	16,643	$1.00M
99480	Subsequent intensive care, per day, low birth weight infant	<1%	11,611	$986K
86920		<1%	11,038	$982K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	622	$927K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	21,666	$908K
36512		<1%	1,449	$890K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	1,413	$886K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,411	$884K
99203	Doctor's office visit, new patient (routine)	<1%	20,615	$837K
84443	Thyroid stimulating hormone (TSH)	<1%	64,687	$833K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	15,762	$830K
99223	Prolong inpt eval add15 m	<1%	11,601	$829K
72170		<1%	16,158	$784K
86901		<1%	47,836	$778K
77077		<1%	13,431	$765K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	11,799	$754K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	11,852	$732K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	49,846	$720K
76825		<1%	3,186	$718K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	11,681	$709K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	34,227	$707K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	481	$704K
D7140	Extraction, erupted tooth or exposed root	<1%	1,178	$659K
99205	Prolong outpt/office vis	<1%	7,172	$652K
87536		<1%	12,607	$642K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	17,018	$628K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	12,404	$626K
96375	Therapeutic injection; each additional sequential IV push	<1%	22,979	$611K
99170		<1%	7,663	$609K
49591		<1%	284	$589K
94726		<1%	6,525	$589K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	15,847	$582K
72141		<1%	4,732	$577K
93320		<1%	36,613	$576K
73590		<1%	16,673	$572K
77412		<1%	5,127	$570K
72156		<1%	3,011	$568K
88342		<1%	10,489	$567K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	33,754	$567K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	10,234	$567K
76000		<1%	4,688	$566K
96367		<1%	13,004	$566K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	5,792	$554K
97161		<1%	11,042	$552K
73562		<1%	18,651	$545K
73610		<1%	16,472	$545K
31720		<1%	4,788	$541K
01922		<1%	5,252	$536K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	4,312	$536K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	117,766	$531K
95782		<1%	871	$527K
73630		<1%	15,470	$524K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	3,729	$523K
A0425	Ground mileage, per statute mile	<1%	2,078	$518K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	4,051	$506K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	24,446	$504K
72158		<1%	2,555	$497K
93308		<1%	7,048	$496K
77334		<1%	1,847	$495K
80048	Basic metabolic panel (calcium, ionized)	<1%	74,355	$493K
96415		<1%	8,834	$492K
72157		<1%	2,553	$485K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	3,964	$483K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	1,061	$481K
95816		<1%	5,359	$480K
87070		<1%	53,563	$457K
J9310	Injection, rituximab, 100 mg	<1%	176	$452K
81025		<1%	55,030	$447K
93325		<1%	61,168	$446K
64493		<1%	1,069	$445K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	7,008	$445K
74183		<1%	3,297	$439K
83036	Hemoglobin; glycosylated (A1C)	<1%	58,452	$437K
94728		<1%	6,468	$436K
94150		<1%	3,950	$432K
73090		<1%	11,654	$430K
62323		<1%	1,587	$429K
59409	Vaginal delivery only (with or without episiotomy and/or forceps)	<1%	720	$425K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	11,004	$423K
80061	Lipid panel	<1%	41,713	$422K
85027		<1%	86,769	$414K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	21,653	$414K
76821		<1%	8,348	$405K
83880		<1%	19,045	$402K
73552		<1%	12,847	$402K
81001		<1%	101,066	$399K
59514		<1%	646	$393K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	8,236	$387K
54640		<1%	197	$384K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	18,606	$384K
72125	Computed tomography, cervical spine; without contrast material	<1%	8,840	$381K
86003		<1%	8,056	$380K
92579		<1%	4,375	$380K
73130		<1%	9,479	$373K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	17,516	$366K
97165		<1%	6,636	$365K
73030		<1%	12,793	$355K
77072		<1%	4,865	$355K
67311		<1%	181	$350K
70496		<1%	5,188	$347K
86870		<1%	2,693	$346K
70491		<1%	3,647	$342K
77336		<1%	5,279	$341K
43762		<1%	3,593	$341K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	4,747	$341K
93451		<1%	511	$339K
82728		<1%	35,219	$333K
01967	Neuraxial labor analgesia/anesthesia for planned vaginal delivery	<1%	1,046	$329K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	28,166	$328K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	16,858	$327K
86360		<1%	11,675	$325K
20610		<1%	6,266	$322K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	7,305	$322K
77300		<1%	1,432	$320K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	6,391	$312K
82803		<1%	22,472	$311K
S9110	Telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month	<1%	38,622	$311K
95720		<1%	2,545	$311K
59425		<1%	3,912	$304K
J1453	Injection, fosaprepitant, 1 mg	<1%	2,337	$302K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	3,282	$300K
92060		<1%	6,809	$299K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	5,065	$298K
73110		<1%	7,485	$297K
A0427	Emergency ambulance ride, advanced life support	<1%	1,237	$297K
71275	Computed tomographic angiography, chest, with contrast material	<1%	4,336	$293K
70498		<1%	4,868	$289K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,671	$287K
92526		<1%	6,956	$284K
73560		<1%	8,337	$284K
88184		<1%	2,148	$282K
87086	Culture, bacterial; quantitative colony count, urine	<1%	43,415	$275K
73080		<1%	6,758	$270K
76536		<1%	5,481	$270K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	13,967	$265K
72100		<1%	5,832	$265K
93017		<1%	2,853	$262K
84439		<1%	33,425	$262K
95811		<1%	544	$261K
96417		<1%	6,415	$259K
92523		<1%	2,095	$257K
93976		<1%	6,286	$256K
82947		<1%	90,920	$255K
99242		<1%	4,701	$250K
92567		<1%	13,535	$246K
95700		<1%	2,051	$245K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	769	$243K
19083		<1%	456	$242K
99245		<1%	2,116	$241K
90960	End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits	<1%	2,810	$239K
72197		<1%	1,198	$239K
96523		<1%	9,039	$238K
96130		<1%	2,953	$238K
70486		<1%	4,026	$237K
93970		<1%	5,946	$236K
99220		<1%	2,205	$236K
59426		<1%	2,657	$236K
71250		<1%	5,726	$233K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	998	$232K
73060		<1%	5,867	$231K
99460		<1%	3,806	$231K
82248		<1%	56,209	$230K
93886		<1%	1,430	$228K
92015	Determination of refractive state	<1%	11,543	$228K
73100		<1%	5,602	$227K
99255		<1%	2,426	$226K
83970		<1%	9,619	$226K
86780		<1%	25,478	$221K
73620		<1%	5,035	$220K
72146		<1%	1,324	$219K
43235		<1%	855	$219K
76642		<1%	7,883	$218K
74178		<1%	1,645	$213K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	9,094	$213K
94762		<1%	3,209	$211K
83605		<1%	29,246	$205K
73070		<1%	4,550	$205K
90834	Psychotherapy session, about 45 minutes	<1%	4,395	$204K
70543		<1%	876	$204K
72040		<1%	5,932	$203K
73120		<1%	2,786	$202K
92585		<1%	1,201	$201K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	3,149	$200K
76827		<1%	3,594	$197K
86832		<1%	1,369	$196K
73502		<1%	7,445	$195K
86833		<1%	1,369	$194K
42821		<1%	108	$193K
74019		<1%	3,489	$191K
83735		<1%	47,816	$191K
12011		<1%	1,596	$190K
64643		<1%	7,905	$190K
93225		<1%	2,286	$189K
96409		<1%	1,627	$189K
87563		<1%	8,295	$187K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	8,357	$186K
74230		<1%	3,314	$185K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,727	$185K
70250		<1%	3,011	$180K
74022		<1%	4,728	$179K
93975		<1%	1,538	$178K
86235		<1%	4,829	$177K
95819		<1%	2,034	$177K
94060		<1%	1,301	$176K
99201		<1%	8,519	$175K
77066	Tomosynthesis, mammo	<1%	3,512	$174K
95911		<1%	729	$174K
87077		<1%	23,674	$170K
92652		<1%	1,180	$169K
99462		<1%	5,656	$169K
J9070	Cyclophosphamide, 100 mg	<1%	687	$168K
85046		<1%	37,286	$167K
76830	Ultrasound, transvaginal	<1%	3,305	$166K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,690	$165K
99239	Hospital discharge day management, more than 30 minutes	<1%	3,967	$164K
31231		<1%	1,298	$163K
80047		<1%	20,346	$163K
99468		<1%	437	$159K
99254		<1%	2,276	$157K
73564		<1%	1,380	$156K
86481		<1%	2,451	$156K
44970		<1%	31	$156K
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	464	$155K
83021		<1%	12,100	$153K
97162		<1%	3,888	$153K
86140		<1%	36,707	$152K
80074		<1%	4,752	$151K
96401		<1%	4,772	$150K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	631	$148K
80069		<1%	24,672	$147K
92588		<1%	903	$147K
99253		<1%	2,205	$146K
90792	Psychiatric diagnostic evaluation with medical services	<1%	1,942	$146K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	537	$145K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	3,260	$143K
86480		<1%	3,491	$143K
83655		<1%	12,662	$141K
76506		<1%	5,636	$140K
92582		<1%	1,692	$140K
93880		<1%	2,148	$139K
85610		<1%	49,654	$139K
97116		<1%	11,097	$138K
76801		<1%	2,194	$138K
96131		<1%	2,166	$137K
77065	Tomosynthesis, mammo	<1%	3,266	$137K
88304		<1%	6,022	$134K
74240		<1%	1,588	$134K
10060		<1%	1,047	$133K
72070		<1%	2,401	$129K
49083		<1%	427	$128K
82784		<1%	15,710	$128K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	433	$127K
93321		<1%	18,095	$125K
86077		<1%	4,723	$123K
49650		<1%	43	$122K
99222	Initial hospital care, per day, moderate complexity	<1%	3,276	$122K
69210		<1%	3,539	$122K
72190		<1%	2,132	$121K
31575		<1%	2,085	$120K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	43,489	$120K
84403		<1%	5,396	$117K
92597		<1%	1,863	$116K
90832	Psychotherapy session, about 30 minutes	<1%	3,150	$116K
93971		<1%	4,160	$115K
87040		<1%	14,664	$115K
84484		<1%	13,926	$115K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,688	$115K
84702		<1%	10,967	$115K
74455		<1%	1,002	$115K
82570		<1%	28,546	$113K
59025	Fetal non-stress test	<1%	3,105	$112K
78816		<1%	211	$111K
97166		<1%	2,619	$110K
93922		<1%	3,745	$109K
87186		<1%	16,602	$109K
96101		<1%	1,039	$109K
81003		<1%	50,093	$108K
86160		<1%	14,779	$107K
01961		<1%	431	$107K
84100		<1%	37,614	$106K
80197		<1%	13,988	$103K
95813		<1%	714	$103K
95115		<1%	3,382	$103K
74170		<1%	1,179	$103K
85730		<1%	24,792	$102K
82607		<1%	10,513	$101K
69631		<1%	33	$101K
93296		<1%	7,716	$100K
88185		<1%	2,547	$99K
12001		<1%	924	$99K
36556		<1%	248	$99K
78306		<1%	853	$99K
77301		<1%	191	$97K
76870		<1%	1,405	$97K
77295		<1%	142	$97K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	9,219	$97K
75625		<1%	150	$96K
73600		<1%	1,842	$96K
72110		<1%	1,749	$96K
90472	Immunization administration, each additional vaccine (list separately)	<1%	8,262	$96K
J2997	Injection, alteplase recombinant, 1 mg	<1%	614	$95K
17110		<1%	1,363	$94K
80076		<1%	14,559	$92K
88300		<1%	8,243	$92K
T1017	Case management, billed per 15 minutes	<1%	2,008	$91K
43760		<1%	701	$91K
83550		<1%	15,923	$90K
64450		<1%	346	$90K
82330		<1%	10,008	$89K
95874		<1%	10,359	$87K
92134		<1%	7,958	$87K
11043		<1%	537	$87K
87497		<1%	5,404	$85K
83516		<1%	5,884	$85K
96411		<1%	1,481	$85K
94664		<1%	4,843	$85K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	89	$84K
51701		<1%	1,307	$84K
J1602	Injection, golimumab, 1 mg, for intravenous use	<1%	66	$84K
76885		<1%	1,544	$82K
29450		<1%	619	$81K
93000		<1%	6,499	$80K
90670		<1%	21,984	$80K
83615		<1%	18,527	$80K
87807		<1%	7,558	$79K
37225		<1%	56	$78K
97533		<1%	2,498	$78K
87522	Neg quan hep c or qual rna	<1%	2,735	$77K
73700		<1%	1,188	$75K
49593		<1%	33	$75K
90686		<1%	28,355	$75K
93798		<1%	3,039	$74K
83540		<1%	17,304	$73K
83002		<1%	4,375	$73K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	5,961	$73K
77470		<1%	286	$72K
82533		<1%	5,202	$72K
73000		<1%	1,398	$71K
67028	Intravitreal injection of a pharmacologic agent	<1%	1,561	$71K
12002		<1%	519	$71K
84156		<1%	25,797	$70K
82785		<1%	5,715	$70K
83520		<1%	5,075	$69K
29125		<1%	954	$69K
82550		<1%	12,291	$68K
83001		<1%	4,288	$68K
88173		<1%	2,426	$67K
96137		<1%	1,574	$67K
82670		<1%	2,816	$67K
94250		<1%	1,398	$66K
85660		<1%	18,894	$66K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	34	$65K
86147		<1%	1,253	$65K
84402		<1%	2,761	$65K
85652		<1%	30,243	$65K
96450		<1%	475	$65K
88141		<1%	4,375	$64K
85007		<1%	21,383	$64K
92551		<1%	9,819	$64K
P9011	Blood, split unit	<1%	836	$64K
62270		<1%	224	$64K
87340		<1%	9,783	$63K
87906		<1%	925	$62K
J2182	Injection, mepolizumab, 1 mg	<1%	37	$61K
72050		<1%	1,072	$61K
86803		<1%	6,972	$61K
88108		<1%	4,518	$60K
84305		<1%	3,309	$59K
92611		<1%	1,160	$59K
88313		<1%	2,453	$59K
99442		<1%	2,411	$59K
77014		<1%	2,206	$58K
83690		<1%	12,724	$58K
77290		<1%	297	$58K
36591		<1%	13,109	$58K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	1,101	$57K
95715		<1%	244	$57K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	337	$57K
74220		<1%	540	$56K
96136		<1%	1,927	$55K
82375		<1%	7,441	$54K
86038		<1%	5,685	$54K
82043		<1%	13,069	$54K
88341		<1%	6,473	$53K
84153		<1%	4,718	$53K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	2,816	$53K
70544		<1%	465	$53K
31624		<1%	183	$52K
86317		<1%	1,598	$52K
87799		<1%	4,870	$52K
82105		<1%	4,712	$52K
99471		<1%	115	$51K
99217		<1%	1,223	$51K
73522		<1%	1,025	$51K
73221		<1%	447	$50K
86376		<1%	3,977	$50K
82746		<1%	5,380	$49K
95117		<1%	1,828	$49K
72131		<1%	972	$49K
62370		<1%	551	$49K
80177		<1%	4,563	$49K
88312		<1%	2,004	$49K
84550		<1%	14,804	$48K
90732		<1%	980	$48K
77075		<1%	767	$48K
78708		<1%	221	$48K
82610		<1%	3,944	$48K
93295		<1%	2,984	$48K
75561		<1%	235	$47K
86762		<1%	4,923	$47K
99221		<1%	1,159	$47K
82810		<1%	7,699	$47K
87205		<1%	13,920	$46K
84146		<1%	2,788	$46K
86225		<1%	4,783	$45K
86880		<1%	1,825	$45K
97542		<1%	1,618	$45K
82565		<1%	13,444	$44K
92553		<1%	804	$44K
31622		<1%	105	$44K
83498		<1%	1,771	$43K
96161		<1%	9,637	$43K
86592		<1%	12,115	$42K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	51	$42K
82627		<1%	2,051	$42K
90734		<1%	2,044	$42K
82024		<1%	1,374	$41K
96402		<1%	1,164	$41K
92557		<1%	673	$41K
93923		<1%	993	$41K
85018		<1%	22,082	$41K
71271		<1%	1,015	$41K
99443		<1%	1,024	$41K
L8613	Ossicula implant	<1%	1,225	$41K
J9267	Injection, paclitaxel, 1 mg	<1%	2,566	$40K
99173		<1%	14,465	$39K
93531		<1%	47	$39K
87507		<1%	143	$39K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	722	$39K
36561		<1%	27	$38K
83883		<1%	2,887	$38K
76937		<1%	15,583	$38K
82378		<1%	2,881	$37K
A0225	Ambulance service, neonatal transport, base rate, emergency transport, one way	<1%	196	$37K
86706		<1%	5,126	$37K
J9045	Injection, carboplatin, 50 mg	<1%	3,057	$36K
84165		<1%	5,807	$36K
51600		<1%	1,225	$36K
77338		<1%	268	$36K
90461		<1%	17,330	$36K
90750		<1%	497	$35K
00126		<1%	620	$35K
74174		<1%	293	$35K
P9041	Infusion, albumin (human), 5%, 50 ml	<1%	514	$35K
93458		<1%	31	$35K
86704		<1%	4,495	$35K
83050		<1%	7,588	$34K
82977		<1%	6,481	$34K
73720		<1%	143	$34K
75710		<1%	74	$34K
54360		<1%	15	$33K
86039		<1%	3,838	$32K
90961		<1%	475	$32K
85045		<1%	11,390	$32K
99381		<1%	666	$32K
84132		<1%	12,533	$31K
64635		<1%	41	$31K
87517		<1%	1,374	$31K
93282		<1%	1,927	$31K
21235		<1%	12	$30K
76604		<1%	691	$30K
76857		<1%	553	$30K
54300		<1%	15	$30K
93297		<1%	2,890	$30K
86255		<1%	2,031	$29K
96373		<1%	418	$28K
81373		<1%	606	$28K
80164		<1%	2,739	$28K
49500		<1%	18	$28K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	51	$28K
87102		<1%	4,441	$28K
J9041	Injection, bortezomib, 0.1 mg	<1%	136	$28K
27096		<1%	362	$28K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	181	$28K
86146		<1%	690	$28K
62328		<1%	110	$28K
74270		<1%	311	$27K
85014		<1%	18,856	$27K
93280		<1%	1,870	$27K
72120		<1%	423	$27K
80143		<1%	1,873	$27K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	3,346	$27K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	22,372	$27K
87535		<1%	1,005	$26K
90651		<1%	2,335	$26K
92610		<1%	667	$26K
86787		<1%	3,012	$26K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	433	$26K
87045		<1%	2,543	$26K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	4,772	$26K
95822		<1%	968	$25K
86800		<1%	1,970	$25K
77427		<1%	997	$25K
86665		<1%	1,616	$25K
84295		<1%	10,422	$24K
70480		<1%	358	$24K
76882		<1%	340	$24K
87081		<1%	5,606	$24K
76377		<1%	1,178	$24K
99235		<1%	242	$24K
82139		<1%	1,702	$24K
00920		<1%	353	$23K
83519		<1%	1,481	$23K
80179		<1%	1,640	$23K
87075		<1%	3,456	$23K
93298		<1%	1,642	$23K
99219		<1%	315	$23K
86304		<1%	1,762	$22K
27606		<1%	15	$22K
83525		<1%	2,116	$22K
86200		<1%	2,416	$22K
A4565	Slings	<1%	1,462	$21K
82820		<1%	3,325	$21K
81243		<1%	1,340	$21K
01920		<1%	126	$21K
64615		<1%	172	$20K
84681		<1%	1,269	$20K
72128		<1%	358	$20K
86790		<1%	2,308	$20K
85379		<1%	2,519	$19K
87046		<1%	2,540	$19K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	495	$19K
77370		<1%	309	$19K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	24	$19K
C1769	Guide wire	<1%	9,896	$19K
86355		<1%	675	$18K
69200		<1%	384	$18K
95886		<1%	2,212	$18K
87486		<1%	634	$18K
29580		<1%	263	$18K
87581		<1%	634	$18K
93356		<1%	1,478	$18K
77280		<1%	215	$17K
87210		<1%	5,420	$17K
92555		<1%	2,522	$17K
86359		<1%	605	$17K
78803		<1%	72	$17K
73140		<1%	330	$16K
85060		<1%	1,473	$16K
84134		<1%	1,759	$16K
88172		<1%	206	$16K
J1726	Injection, hydroxyprogesterone caproate, (makena), 10 mg	<1%	60	$16K
J7030	Infusion, normal saline solution , 1000 cc	<1%	14,200	$16K
86334		<1%	1,664	$16K
86431		<1%	3,567	$15K
82340		<1%	2,564	$15K
92504		<1%	840	$15K
93242		<1%	725	$15K
93283		<1%	962	$15K
86301		<1%	1,066	$15K
82247		<1%	3,600	$15K
99441		<1%	944	$15K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	1,928	$15K
19081		<1%	26	$15K
99051		<1%	1,352	$15K
82379		<1%	985	$14K
00731		<1%	550	$14K
95910		<1%	103	$14K
11044		<1%	45	$14K
80235		<1%	815	$14K
70546		<1%	79	$14K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	63,833	$14K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	50,597	$14K
82140		<1%	1,336	$14K
88311		<1%	3,066	$14K
77076		<1%	223	$14K
92133		<1%	1,561	$13K
82435		<1%	5,330	$13K
87899		<1%	1,724	$13K
85097		<1%	129	$13K
84480		<1%	1,135	$13K
84244		<1%	783	$13K
95885		<1%	1,083	$13K
87116		<1%	1,758	$13K
95251		<1%	1,000	$13K
86696		<1%	941	$13K
85384		<1%	1,949	$13K
76080		<1%	65	$13K
85347		<1%	3,660	$12K
J0178	Injection, aflibercept, 1 mg	<1%	17	$12K
C1776	Joint device (implantable)	<1%	423	$12K
86357		<1%	457	$12K
84446		<1%	1,160	$12K
82150		<1%	2,677	$12K
94729		<1%	5,380	$12K
76981		<1%	1,911	$12K
58100		<1%	201	$12K
95713		<1%	48	$12K
25605		<1%	17	$12K
90620		<1%	348	$12K
J9370	Vincristine sulfate, 1 mg	<1%	3,367	$12K
76775		<1%	263	$12K
81404		<1%	647	$12K
36593		<1%	99	$11K
84450		<1%	2,690	$11K
G0381	Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	386	$11K
85613		<1%	929	$11K
95909		<1%	93	$11K
J3489	Injection, zoledronic acid, 1 mg	<1%	803	$11K
92604		<1%	174	$11K
89051		<1%	2,838	$11K
90962		<1%	245	$11K
94642		<1%	115	$10K
85397		<1%	421	$10K
99308	Subsequent nursing facility care, per day, straightforward	<1%	697	$10K
84238		<1%	504	$10K
82085		<1%	1,340	$10K
83935		<1%	1,801	$10K
36000		<1%	4,913	$10K
83010		<1%	1,263	$10K
00790		<1%	95	$10K
69209		<1%	261	$10K
C1760	Closure device, vascular (implantable/insertable)	<1%	3,029	$10K
V5020	Conformity evaluation	<1%	1,468	$10K
82088		<1%	351	$10K
51798		<1%	1,621	$10K
82157		<1%	389	$10K
G0382	Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	425	$10K
82542		<1%	500	$9K
38222		<1%	15	$9K
90674		<1%	1,734	$9K
92552		<1%	1,021	$9K
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	356	$9K
86695		<1%	938	$9K
87430		<1%	401	$9K
99252		<1%	231	$9K
80306		<1%	699	$9K
86644		<1%	821	$9K
80183		<1%	804	$9K
99236	Prolong inpt eval add15 m	<1%	69	$9K
99152		<1%	7,035	$8K
99457		<1%	1,111	$8K
93312		<1%	56	$8K
80203		<1%	831	$8K
85240		<1%	566	$8K
84590		<1%	1,006	$8K
93284		<1%	771	$8K
64644		<1%	43	$8K
50435		<1%	12	$8K
77012		<1%	770	$8K
72081		<1%	768	$8K
99383		<1%	155	$8K
85246		<1%	410	$8K
99382		<1%	173	$8K
D7210	Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth	<1%	13	$8K
84445		<1%	200	$8K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	480	$8K
0071A		<1%	362	$8K
90715		<1%	3,806	$7K
96160		<1%	3,745	$7K
83789		<1%	387	$7K
29105		<1%	99	$7K
93246		<1%	325	$7K
84425		<1%	609	$7K
88189		<1%	137	$7K
88346		<1%	90	$7K
99417	Prolong home eval add 15m	<1%	1,141	$7K
84478		<1%	1,124	$7K
86063		<1%	1,427	$7K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	1,561	$7K
11981		<1%	91	$6K
94618		<1%	147	$6K
87902		<1%	34	$6K
81406		<1%	893	$6K
82951		<1%	683	$6K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	65,055	$6K
82657		<1%	368	$6K
85732		<1%	1,221	$6K
11900		<1%	211	$6K
94070		<1%	50	$6K
87206		<1%	1,621	$6K
80195		<1%	697	$6K
92083		<1%	346	$5K
86215		<1%	398	$5K
86777		<1%	595	$5K
12013		<1%	56	$5K
49465		<1%	70	$5K
99454		<1%	800	$5K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	26,581	$5K
00840		<1%	107	$5K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	46	$5K
82164		<1%	472	$5K
92081		<1%	139	$5K
D2940		<1%	109	$5K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	241	$5K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	95	$5K
64405		<1%	48	$5K
0072A		<1%	295	$5K
82652		<1%	213	$5K
84460		<1%	997	$5K
31500		<1%	100	$5K
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	<1%	2,537	$5K
80299		<1%	385	$5K
94010		<1%	637	$5K
85651		<1%	1,603	$5K
82017		<1%	337	$5K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	2,145	$4K
D1120	Dental cleaning, child	<1%	104	$4K
70360		<1%	122	$4K
84166		<1%	567	$4K
0296T		<1%	410	$4K
93299		<1%	249	$4K
36620		<1%	473	$4K
87420		<1%	299	$4K
99464		<1%	304	$4K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	3,776	$4K
00400		<1%	72	$4K
99354		<1%	56	$4K
83919		<1%	247	$4K
81405		<1%	714	$4K
86860		<1%	44	$4K
78264		<1%	39	$4K
92595		<1%	934	$4K
J1756	Injection, iron sucrose, 1 mg	<1%	3,689	$4K
77080		<1%	252	$4K
T1023	Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter	<1%	337	$4K
J1097	Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml	<1%	773	$4K
A9562	Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries	<1%	142	$4K
82731		<1%	74	$4K
82390		<1%	463	$4K
99490	Ccm add 20min	<1%	1,030	$4K
96377		<1%	238	$4K
99384		<1%	96	$4K
54162		<1%	25	$4K
97014		<1%	470	$4K
90746		<1%	92	$4K
84210		<1%	337	$4K
L4386	Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	562	$4K
J1170	Injection, hydromorphone, up to 4 mg	<1%	12,027	$4K
96910		<1%	84	$4K
84157		<1%	1,225	$4K
99465		<1%	86	$4K
86337		<1%	220	$4K
72192		<1%	123	$4K
99358	Prolong nursin fac eval 15m	<1%	146	$4K
11100		<1%	71	$4K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	52	$4K
V5264	Ear mold/insert, not disposable, any type	<1%	1,381	$4K
29065		<1%	68	$4K
99477		<1%	15	$4K
86162		<1%	348	$4K
82310		<1%	1,190	$4K
62322		<1%	111	$4K
S9445	Patient education, not otherwise classified, non-physician provider, individual, per session	<1%	2,284	$4K
36416		<1%	27,199	$4K
86593		<1%	1,268	$3K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	13	$3K
82945		<1%	1,053	$3K
17250		<1%	65	$3K
90656		<1%	1,214	$3K
90945		<1%	134	$3K
11982		<1%	13	$3K
88333		<1%	19	$3K
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	<1%	2,273	$3K
83835		<1%	237	$3K
95712		<1%	16	$3K
31615		<1%	28	$3K
29075		<1%	49	$3K
00300		<1%	49	$3K
73521		<1%	44	$3K
91040		<1%	46	$3K
84481		<1%	230	$3K
84207		<1%	158	$3K
80175		<1%	317	$3K
77263		<1%	28	$3K
97016		<1%	152	$3K
88331		<1%	69	$3K
96376		<1%	5,292	$3K
96368		<1%	1,323	$3K
76818		<1%	59	$3K
10005		<1%	13	$3K
80185		<1%	258	$3K
90710		<1%	1,349	$3K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	5,684	$3K
90966		<1%	75	$3K
88302		<1%	395	$3K
76942		<1%	2,474	$3K
29581		<1%	64	$3K
01968		<1%	46	$3K
95990		<1%	13	$3K
20552		<1%	15	$2K
77001		<1%	1,022	$2K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	310	$2K
90870		<1%	33	$2K
80201		<1%	228	$2K
Q4036	Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass	<1%	99	$2K
82016		<1%	278	$2K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	287	$2K
C9447	Injection, phenylephrine and ketorolac, 4 ml vial	<1%	21	$2K
81407		<1%	418	$2K
88142		<1%	522	$2K
11104		<1%	53	$2K
82172		<1%	158	$2K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	64	$2K
96132		<1%	45	$2K
84155		<1%	2,029	$2K
77002		<1%	1,578	$2K
86364		<1%	707	$2K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	4,709	$2K
93285		<1%	116	$2K
J1815	Injection, insulin, per 5 units	<1%	1,945	$2K
93271		<1%	33	$2K
41010		<1%	24	$2K
17311		<1%	14	$2K
96133		<1%	25	$2K
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	<1%	1,431	$2K
51702		<1%	32	$2K
87338		<1%	157	$2K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	34,533	$2K
75630		<1%	118	$2K
81050		<1%	692	$2K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	53	$2K
86308		<1%	408	$2K
86684		<1%	182	$2K
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	1,112	$2K
87493		<1%	66	$2K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	108	$2K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	2,182	$2K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	9,116	$2K
75635		<1%	16	$2K
99475		<1%	14	$2K
90785		<1%	274	$2K
00750		<1%	13	$2K
81380		<1%	50	$2K
00320		<1%	25	$2K
81403		<1%	200	$2K
L4360	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	75	$2K
93227		<1%	92	$2K
J7999	Compounded drug, not otherwise classified	<1%	187	$1K
31579		<1%	44	$1K
77332		<1%	19	$1K
86711		<1%	276	$1K
90633		<1%	7,368	$1K
93294		<1%	152	$1K
88112		<1%	150	$1K
00140		<1%	48	$1K
83993		<1%	95	$1K
81332		<1%	94	$1K
L8509	Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type	<1%	777	$1K
90696		<1%	1,136	$1K
82103		<1%	99	$1K
83930		<1%	324	$1K
52000		<1%	15	$1K
70487		<1%	18	$1K
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	403	$1K
94617		<1%	20	$1K
92626		<1%	30	$1K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	3,639	$1K
64400		<1%	13	$1K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	286	$1K
99306	Prolong nursin fac eval 15m	<1%	12	$1K
87449		<1%	207	$1K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	6,694	$1K
00160		<1%	16	$1K
86677		<1%	86	$1K
J9171	Injection, docetaxel, 1 mg	<1%	17	$1K
83921		<1%	81	$1K
93793		<1%	538	$1K
84466		<1%	151	$1K
V5010	Assessment for hearing aid	<1%	310	$1K
83521		<1%	1,362	$1K
93279		<1%	43	$1K
82010		<1%	204	$1K
V5140	Binaural, behind the ear	<1%	21	$1K
90756		<1%	78	$1K
86060		<1%	130	$1K
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	2,062	$1K
81002		<1%	443	$1K
92082		<1%	78	$1K
96112		<1%	21	$1K
76828		<1%	18	$1K
85670		<1%	264	$1K
82465		<1%	308	$1K
G0296	Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)	<1%	94	$1K
73660		<1%	22	$1K
94200		<1%	194	$997.34
00813		<1%	18	$990.00
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	148	$983.30
90677		<1%	3,298	$982.16
0124A		<1%	63	$955.66
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,583	$955.50
99458		<1%	364	$947.13
96127		<1%	290	$941.68
84432		<1%	91	$930.13
87015		<1%	228	$920.57
81370		<1%	16	$907.02
J9260	Injection, methotrexate sodium, 50 mg	<1%	901	$906.45
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	29	$891.55
83701		<1%	45	$877.09
86341		<1%	662	$876.02
99401		<1%	44	$875.06
A6209	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	1,147	$863.82
86705		<1%	126	$845.84
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	2,149	$784.38
84520		<1%	187	$774.60
93926		<1%	13	$773.71
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	114	$764.84
96118		<1%	43	$763.46
51784		<1%	43	$744.36
82955		<1%	111	$733.67
58300		<1%	16	$731.62
93226		<1%	16	$728.40
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	4,656	$714.97
85520		<1%	70	$706.18
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	263	$704.70
73650		<1%	24	$699.65
76776		<1%	32	$699.11
0001A		<1%	54	$697.81
87076		<1%	135	$676.71
87901		<1%	632	$676.34
82787		<1%	30	$664.39
00520		<1%	19	$662.20
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	99	$661.56
96138		<1%	263	$651.55
84630		<1%	80	$650.76
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	365	$635.54
88350		<1%	23	$634.91
J7510	Prednisolone oral, per 5 mg	<1%	2,020	$632.92
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	<1%	15	$630.10
99195		<1%	14	$626.50
00635		<1%	14	$625.23
86664		<1%	66	$625.15
95012		<1%	404	$622.66
82952		<1%	221	$620.22
88177		<1%	147	$598.04
G0008	Administration of influenza virus vaccine	<1%	471	$568.38
J0640	Injection, leucovorin calcium, per 50 mg	<1%	19	$566.72
90698		<1%	5,007	$565.60
93978		<1%	34	$564.73
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,447	$557.81
95941		<1%	13	$552.00
93270		<1%	17	$547.06
86335		<1%	65	$546.09
86618		<1%	38	$539.67
86663		<1%	66	$536.44
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	65	$534.14
72080		<1%	15	$528.56
Q4008	Cast supplies, long arm cast, pediatric (0-10 years), fiberglass	<1%	48	$527.07
85049		<1%	151	$522.14
V5011	Fitting/orientation/checking of hearing aid	<1%	2,812	$521.10
95938		<1%	13	$515.71
87529		<1%	22	$512.46
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	<1%	664	$507.63
75774		<1%	134	$507.48
82040		<1%	191	$503.66
86769		<1%	13	$498.04
84154		<1%	41	$494.24
64494		<1%	1,011	$460.39
74021		<1%	20	$460.08
87184		<1%	95	$457.36
J1650	Injection, enoxaparin sodium, 10 mg	<1%	7,967	$455.47
99307		<1%	143	$449.53
G0452	Molecular pathology procedure; physician interpretation and report	<1%	16	$448.54
V2020	Frames, purchases	<1%	116	$448.11
80169		<1%	46	$438.41
0173A		<1%	23	$433.53
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	2,409	$420.65
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	2,206	$415.51
99091		<1%	58	$415.23
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	19	$396.66
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	185	$395.96
87181		<1%	74	$394.33
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	2,078	$391.20
V5160	Dispensing fee, binaural	<1%	44	$390.00
0077U		<1%	474	$388.96
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	136	$384.43
83020		<1%	33	$382.33
81408		<1%	92	$379.71
78582		<1%	14	$375.59
90647		<1%	7,630	$374.33
G0380	Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	147	$363.30
95718		<1%	16	$353.82
J9250	Methotrexate sodium, 5 mg	<1%	646	$353.48
87209		<1%	26	$348.90
C1780	Lens, intraocular (new technology)	<1%	29	$348.00
J1953	Injection, levetiracetam, 10 mg	<1%	2,955	$344.43
99251		<1%	18	$326.81
83090		<1%	36	$320.46
90700		<1%	114	$320.00
87641		<1%	13	$313.14
99156		<1%	16	$298.33
90714		<1%	2,366	$295.26
90688		<1%	23	$291.34
J3370	Injection, vancomycin hcl, 500 mg	<1%	4,239	$287.99
87400		<1%	28	$281.76
82626		<1%	13	$277.43
87305		<1%	51	$274.23
99453		<1%	96	$272.16
81511		<1%	1,202	$272.00
86645		<1%	23	$265.11
J9190	Injection, fluorouracil, 500 mg	<1%	36	$264.73
00811		<1%	14	$263.03
36247		<1%	439	$262.27
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	4,377	$261.20
90707		<1%	1,272	$241.83
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	27,666	$237.96
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	635	$236.88
A4648	Tissue marker, implantable, any type, each	<1%	991	$236.00
77003		<1%	14	$235.83
93244		<1%	18	$234.87
86648		<1%	12	$225.24
A9901	Dme delivery, set up, and/or dispensing service component of another hcpcs code	<1%	52	$225.00
D0210	Intraoral - complete series of radiographic images	<1%	13	$222.66
C1889	Implantable/insertable device, not otherwise classified	<1%	60	$220.84
36568		<1%	19	$217.59
58340		<1%	18	$210.30
95806		<1%	14	$203.25
88240		<1%	37	$195.68
84145		<1%	579	$187.26
G0425	Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth	<1%	44	$186.90
86687		<1%	32	$183.40
D1206	Topical application of fluoride varnish	<1%	27	$181.83
93018		<1%	38	$181.22
84075		<1%	47	$178.38
87177		<1%	26	$174.47
93016		<1%	75	$172.62
51736		<1%	28	$169.53
99241		<1%	15	$163.70
80184		<1%	15	$151.47
D0150	Comprehensive oral evaluation - new or established patient	<1%	14	$148.86
80156		<1%	13	$144.69
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	<1%	874	$142.18
86008		<1%	80	$132.85
97535	Self-care/home management training, each 15 minutes	<1%	496	$129.91
87350		<1%	12	$128.07
92340	Fitting of spectacles, except for aphakia; monofocal	<1%	13	$126.88
92250		<1%	26	$121.80
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	631	$117.89
82270		<1%	30	$117.51
90685		<1%	314	$114.85
99226		<1%	183	$113.46
64999		<1%	19	$112.25
93291		<1%	13	$108.59
88334		<1%	16	$106.96
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	419	$106.88
80186		<1%	15	$104.93
93248		<1%	13	$102.70
G0453	Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)	<1%	19	$90.00
J3475	Injection, magnesium sulfate, per 500 mg	<1%	171	$85.52
A6261	Wound filler, gel/paste, per fluid ounce, not otherwise specified	<1%	93	$85.28
95982		<1%	13	$85.11
86005		<1%	12	$82.85
92583		<1%	29	$81.25
90474		<1%	14	$79.92
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	2,778	$78.10
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	<1%	343	$75.20
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	104	$70.46
92594		<1%	108	$69.69
36592		<1%	765	$69.68
84300		<1%	33	$69.12
82525		<1%	14	$67.81
82540		<1%	26	$61.32
87220		<1%	12	$55.63
75716		<1%	12	$55.02
80321		<1%	119	$53.01
0346T		<1%	351	$48.81
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	26	$42.45
D1208	Topical application of fluoride, excluding varnish	<1%	12	$38.10
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	941	$36.33
G8990	Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	117	$34.90
J7321	Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose	<1%	24	$33.63
L4387	Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf	<1%	14	$31.94
G9171	Voice functional limitation, current status at therapy episode outset and at reporting intervals	<1%	113	$28.70
C9113	Injection, pantoprazole sodium, per vial	<1%	1,323	$24.96
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	434	$23.33
A6222	Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	28	$21.10
A6206	Contact layer, sterile, 16 sq. in. or less, each dressing	<1%	17	$20.55
90739		<1%	33	$19.47
A7507	Filter holder and integrated filter without adhesive, for use in a tracheostoma heat and moisture exchange system, each	<1%	263	$16.12
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	568	$15.55
81596		<1%	353	$11.47
J7614	Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg	<1%	45	$9.60
J8540	Dexamethasone, oral, 0.25 mg	<1%	62	$6.27
Q0169	Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	73	$0.70
90681		0%	5,156	$0.00
C1729	Catheter, drainage	0%	2,263	$0.00
J1644	Injection, heparin sodium, per 1000 units	0%	14	$0.00
77062		0%	198	$0.00
A9577	Injection, gadobenate dimeglumine (multihance), per ml	0%	564	$0.00
0502F		0%	7,838	$0.00
64495		0%	269	$0.00
86015		0%	15	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	1,561	$0.00
3078F		0%	324	$0.00
G0444	Annual depression screening, 5 to 15 minutes	0%	85	$0.00
J2800	Injection, methocarbamol, up to 10 ml	0%	1,201	$0.00
3077F		0%	360	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	405	$0.00
64636		0%	25	$0.00
G0473	Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes	0%	79	$0.00
81479	Unlisted molecular pathology procedure	0%	924	$0.00
94667		0%	82	$0.00
C2628	Catheter, occlusion	0%	210	$0.00
C1714	Catheter, transluminal atherectomy, directional	0%	148	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	87	$0.00
L4361	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf	0%	14	$0.00
3046F		0%	99	$0.00
C1788	Port, indwelling (implantable)	0%	58	$0.00
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	0%	68	$0.00
76810		0%	66	$0.00
81401		0%	62	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	233	$0.00
P9073	Platelets, pheresis, pathogen-reduced, each unit	0%	58	$0.00
87631		0%	54	$0.00
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)	0%	23	$0.00
76376		0%	22	$0.00
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	0%	26	$0.00
C1765	Adhesion barrier	0%	18	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	15	$0.00
G0270	Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes	0%	13	$0.00
V5261	Hearing aid, digital, binaural, bte	0%	12	$0.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	0%	411	$0.00
C2623	Catheter, transluminal angioplasty, drug-coated, non-laser	0%	19	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	2,390	$0.00
3008F		0%	8,899	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	541	$0.00
90744		0%	1,475	$0.00
99024		0%	3,489	$0.00
90680		0%	3,186	$0.00
90723		0%	11,252	$0.00
C1892	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away	0%	184	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	413	$0.00
0500F		0%	348	$0.00
V2632	Posterior chamber intraocular lens	0%	1,401	$0.00
94668		0%	952	$0.00
C1877	Stent, non-coated/non-covered, without delivery system	0%	198	$0.00
77417		0%	28	$0.00
G8991	Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	117	$0.00
90716		0%	999	$0.00
3048F		0%	12	$0.00
99153	Mod sedat endo service >5yrs	0%	2,729	$0.00
3080F		0%	280	$0.00
90697		0%	1,247	$0.00
G0009	Administration of pneumococcal vaccine	0%	103	$0.00
3351F		0%	164	$0.00
3074F		0%	311	$0.00
97804		0%	127	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	338	$0.00
3075F		0%	66	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	429	$0.00
A0426	Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)	0%	74	$0.00
L8699	Prosthetic implant, not otherwise specified	0%	99	$0.00
G9172	Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	113	$0.00
3079F		0%	186	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	70	$0.00
3044F		0%	37	$0.00
G8986	Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting	0%	48	$0.00
C1734	Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)	0%	36	$0.00
49424		0%	47	$0.00
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	114	$0.00
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	0%	74	$0.00
C2618	Probe/needle, cryoablation	0%	60	$0.00
0503F		0%	787	$0.00
C1781	Mesh (implantable)	0%	158	$0.00
G9173	Voice functional limitation, discharge status at discharge from therapy or to end reporting	0%	113	$0.00
L3808	Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment	0%	16	$0.00
11045		0%	27	$0.00
76812		0%	32	$0.00
90378		0%	41	$0.00
96139		0%	55	$0.00
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	0%	13	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	18	$0.00
A0434	Specialty care transport (sct)	0%	14	$0.00
3353F		0%	13	$0.00
90619		0%	45	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	23	$0.00
J7507	Tacrolimus, immediate release, oral, 1 mg	0%	34	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGRIMSLEY, JEFFREY (ASSOCIATE CFO-CLINICAL OPERATIONS)

Same official

Other billing entities under GRIMSLEY, JEFFREY

Full network →

Provider	Location	Paid
State of Mississippi - University of Mississippi Medical Center	Canton, MS	$13.96M
State of Mississippi - University of Mississippi Medical Center	Lexington, MS	$7.52M
State of Mississippi - University of Mississippi Medical Center	Lexington, MS	$1.07M
State of Mississippi - University of Mississippi Medical Center	Jackson, MS	$597K
State of Mississippi - University of Mississippi Medical Center	Lexington, MS	$507K
State of Mississippi- University of Mississippi Medical Center	Vaiden, MS	$137K
State of Mississippi - University of Mississippi Medical Center	Jackson, MS	$82K
State of Mississippi-University of Mississippi Medical Center	Grenada, MS	$37K
State of Mississippi - University of Mississippi Medical Center	West, MS	$11K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.